Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 77.40
+0.30 (0.39%)
At close: Dec 17, 2025
TLV:GEFR Revenue
Geffen Residence & Renewal had revenue of 20.00K ILS in the quarter ending September 30, 2025, a decrease of -42.86%. This brings the company's revenue in the last twelve months to 84.00K, down -40.85% year-over-year. In the year 2024, Geffen Residence & Renewal had annual revenue of 131.00K, down -7.75%.
Revenue (ttm)
84.00K
Revenue Growth
-40.85%
P/S Ratio
2,009.86
Revenue / Employee
4.00K
Employees
21
Market Cap
168.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -11.00K | -7.75% |
| Dec 31, 2023 | 142.00K | 82.00K | 136.67% |
| Dec 31, 2022 | 60.00K | -598.00K | -90.88% |
| Dec 31, 2021 | 658.00K | -2.01M | -75.33% |
| Dec 31, 2020 | 2.67M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 162.56M |